Variant report
Variant | nsv980102 |
---|---|
Chromosome Location | chr3:109876026-109882059 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139999544 | chr3:109876035-109876036 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543124683 | chr3:109876073-109876074 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190035949 | chr3:109876109-109876110 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562816275 | chr3:109876127-109876128 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531813336 | chr3:109876144-109876145 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551594564 | chr3:109876164-109876165 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181905718 | chr3:109876189-109876190 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115147061 | chr3:109876194-109876195 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569336950 | chr3:109876202-109876203 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540053683 | chr3:109876235-109876236 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547643216 | chr3:109876246-109876247 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567268294 | chr3:109876255-109876256 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187628599 | chr3:109876290-109876291 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191498645 | chr3:109876291-109876292 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149843725 | chr3:109876303-109876304 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183765040 | chr3:109876340-109876341 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187836932 | chr3:109876359-109876360 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375261856 | chr3:109876426-109876427 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146848297 | chr3:109876428-109876429 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140641856 | chr3:109876470-109876471 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560391057 | chr3:109876473-109876474 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190134358 | chr3:109876526-109876527 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12233453 | chr3:109876529-109876530 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs562884908 | chr3:109876627-109876628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576501071 | chr3:109876676-109876677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545097358 | chr3:109876693-109876694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565142346 | chr3:109876700-109876701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143311670 | chr3:109876744-109876745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534135357 | chr3:109876770-109876771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547705492 | chr3:109876812-109876813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555818361 | chr3:109876814-109876815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200521121 | chr3:109876817-109876818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561451784 | chr3:109876846-109876847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116530741 | chr3:109876858-109876859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549549324 | chr3:109876922-109876923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569628775 | chr3:109876952-109876953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73853159 | chr3:109876962-109876963 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs563025227 | chr3:109876984-109876985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552260491 | chr3:109876986-109876987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577756493 | chr3:109877010-109877011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7434250 | chr3:109877042-109877043 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs34807676 | chr3:109877082-109877083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534784863 | chr3:109877087-109877088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554730301 | chr3:109877094-109877095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146693898 | chr3:109877104-109877105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs34274183 | chr3:109877180-109877181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182040870 | chr3:109877308-109877309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559978301 | chr3:109877378-109877379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186633624 | chr3:109877382-109877383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551606295 | chr3:109877397-109877398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:109876000-109876400 | Enhancers | Fetal Heart | heart |
2 | chr3:109876000-109876600 | Active TSS | Aorta | Aorta |
3 | chr3:109876000-109876600 | Enhancers | HSMMtube | muscle |
4 | chr3:109876200-109876600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr3:109876600-109884400 | Weak transcription | Aorta | Aorta |
6 | chr3:109881600-109882400 | Enhancers | Ovary | ovary |
7 | chr3:109881800-109882800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr3:109882000-109883600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |